Hypertension, or high blood pressure, is a common, serious, and often symptomless condition that can remain dangerously unrecognized for years. Diet modification and pharmacologic interventions to lower blood pressure can affect existing cardiometabolic concerns such as kidney disease and diabetes, so clinicians must be aware of the guidelines in these populations before implementing care.
The latest industry news, CMHC Pulse Blogs and Cardiometabolic Chronicle articles related to hypertension.
Maternal hypertension and hypertensive disorders during pregnancy have been proven to significantly increase the risk of perinatal health complications in both mothers and their offspring.
Despite experiencing an increased risk for hypertension, Black patients often constitute a small proportion of clinical trial participants leading to a lack of data supporting
As results of the REGARDS study indicate, African American patients are more likely to be aware of having hypertension, more likely to be undergoing treatment,
Hypertension is a major risk factor for cardiometabolic disease and is common among the American population with nearly 1 in 3 adults suffering from high
According to a joint statement issued Monday by the American Heart Association and the American College of Cardiology, nearly half of all adult Americans will
More children and teens are likely to be categorized as having abnormal blood pressure during their annual wellness visits, based on new recommendations released this week by
Investigators reported that baxdrostat – at several dose levels – reduced plasma aldosterone levels but not cortisol levels in results from the recent BrigHTN study
A cache of recorded faculty presentations addressing the diagnosis, clinical management, treatment, and emerging strategies related to hypertension.
Cardiometabolic Health Congress co-chair George L. Bakris, MD, provides a brief overview of the evolving landscape of emerging treatment options for resistant hypertension. (Recorded on February 14, 2023)
Blood pressure control and living a healthy lifestyle are key in the management of cardiometabolic risk, however, they can be challenging to optimize in older adults. In this interview, CMHC co-chair Robert Eckel, MD interviews Drs. Dennis Villareal and Dena Rifkin to share some additional perspectives on how to better manage hypertension and encourage healthy lifestyle modifications in this populatio. (Recorded October 19, 2022)
CMHC co-chairs Drs. Robert Eckel, George Bakris, Christie Ballantyne and CMHC Senior Planning Committee members Drs Deepak Bhatt and Keith Ferdinand recap important highlights of key trials and developments in cardiometabolic medicine in 2022, including obesity, hypertension, chronic kidney disease, heart failure, dyslipidemia, atherothrombosis and more. (Recorded October 20, 2022)
A collection of resources related to hypertension for both patients and provider education and connection.
ASO = antisense oligonucleotide; RNAi = RNA interference
Available courses, certification information, and the latest educational opportunities for practitioners interested in beginning or continuing their careers in a cardiometabolic subspecialty with emphasis on hypertension.
Sign up to receive updates on educational opportunities, complimentary content, exclusive discounts, and more.
Cardiometabolic Health Congress
1801 N Military Trail, Ste 110
Boca Raton, FL, 33431
Copyright © 2023, Cardiometabolic Health Congress. All Rights Reserved.
Sign up to receive updates on educational opportunities, complimentary content, exclusive discounts, and more.
